Lung Stent Market 2021 By Regional Statistics, CAGR, Trend & Growth Forecast 2027

Lung Stent Market 2021 By Regional Statistics, CAGR, Trend & Growth Forecast 2027

One of the recent advancements in the lung stent market comprises the approval of the U.S. Food and Drug Administration for the use of 3D printed breathing stents that have been specifically developed for each patient. These patient-specific airway stents are utilized for keeping open the airways of patients having serious breathing disorders and have been developed by Dr. Tom Gildea, the Section Head of Bronchoscopy, Cleveland Clinic.

Further, these lung stents could help people having breathing problems owing to inflammation, tumors, or other illnesses. Until now, the devices were implanted under the Food and Drug Administration’s compassionate use initiative, which permits patients, for whom all the available forms of treatment have failed, to obtain investigational ones that are not available to the public.

Request for a sample copy of this report @  

Similar developments are expected to push lung stent surgery demand, in turn stimulating business growth over the ensuing years. According to the latest research by Global Market Insights, Inc., the global lung stent market size is estimated to surpass USD 348 million by 2026.

An increase in the R&D investments by private and public sector organizations for the development of non-vascular stents is likely to augment lung stent industry expansion through the projected span. The demand for non-vascular stents has been improved since the beginning of investments by the major participants, in turn influencing revenue growth.

Prominent players operating in the global lung stent market comprise Boston Medical Products, Inc., Hood Laboratories, Boston Scientific Corporation, Novatech SA, Micro-Tech (Nanjing) Co., Ltd., and others.

The rising deployment of laryngeal stent for expanding the patient’s airway following surgical reconstruction is expected to drive segment growth over the forecasted period. The laryngeal stent segment accounted for a substantial revenue of over USD 6 million in 2019. These lung stents are also utilized for maintaining lumen in the management of cancer resection or laryngeal trauma.

Moreover, their ability to provide soft support in subglottic stenosis, laryngeal fracture, and laryngeal stenosis is expected to be effective in the treatment of larynx-associated acute respiratory disorders, further bolstering industry expansion.

Request for customization @

The hybrid segment in the global lung stent market is estimated to exhibit a remarkable CAGR of 15.0 per cent over the assessment period. The higher growth of the segment is due to the presence of combined features of metal and silicone with a hydrophilic coating. The hybrid stent is covered with a metallic stent focusing on the minimization of the shortcomings of bare metal and silicone.

These lung stents lead to a minimal in-growth of granulation tissue and are easy to be manipulated upon insertion. Further, some of the hybrid stents have a small loop at their proximal end, in turn enabling a partial collapse and facilitating easy removal. These factors are expected to influence the demand for hybrid lung stent operations over the estimated span.

As per the NBCI (National Center for Biotechnology Information), chronic obstructive pulmonary disease (COPD) is the sixth-most prevalent disease in Brazil. The surging number of patients suffering from airway complications has been instrumental in driving the demand for lung stent for COPD through the estimated period. Brazil accounted for a dominant share of over USD 2 million in the Latin America lung stent market in 2019.

Further, the majority market share is attributed to the escalating number of patients suffering from airway complications as well as the tremendous burning of sugarcane leaves in the country leading to COPD.

In the years to come, the increasing preference for carrying out minimally invasive surgeries for respiratory problems is expected to uplift the demand for stents for lungs, in turn influencing lung stent market  expansion to a significant extent.

Partial Chapter of the Table of Content

Chapter 2   Executive Summary

2.1    Lung stent industry 3600 synopsis, 2015 - 2026

2.1.1    Business trends

2.1.2    Product trends

2.1.3    Device type trends

2.1.4    Material trends

2.1.5    Patient trends

2.1.6    End-use trends

2.1.7    Regional trends

Chapter 3   Lung Stent Industry Insights

3.1    Industry segmentation

3.2    Industry landscape, 2015 – 2026

3.3    Industry impact forces

3.3.1    Growth drivers    Rising prevalence of lung cancer    Growing incidence of COPD and post-tuberculosis stenosis    Increasing investments by the public and private organizations for the development of non-vascular stents    Growing preference for minimally invasive surgeries for respiratory disorders

3.3.2    Industry pitfalls & challenges    Availability of alternative substitute treatment    Stringent regulations

3.4    Growth potential analysis

3.4.1    By product

3.4.2    By device type

3.4.3    By material

3.4.4    By patient

3.4.5    By end-use

3.5    COVID-19 impact analysis

3.6    Reimbursement scenario

3.7    Regulatory landscape

3.8    Technology landscape

3.9    Porters analysis

3.10    Competitive landscape, 2019

3.10.1    Competitive matrix analysis, 2019

3.11    Pestle analysis

Browse complete Table of Contents (ToC) of this research report @